Nu-Med Plus, Inc. (NUMD) stock
NUMDOTCGold and Silver OresFiscal year ends December 31
$0.01−0.00 (-8.16%)
Close on Oct 19, 2026Market cap $601.55KP/E –Yield –
Nu-Med Plus ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Nu-Med Plus's ebitda for the twelve months ending Dec 31, 2022 was -$179.90K. For fiscal 2022 it was -$179.90K. The highest annual figure on record is -$179.90K in fiscal 2022.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | -$179.90K | – |
| FY2021 | Dec 31, 2021 | -$830.08K | – |
| FY2020 | Dec 31, 2020 | -$1.98M | – |
| FY2019 | Dec 31, 2019 | -$1.01M | – |
| FY2018 | Dec 31, 2018 | -$1.15M | – |
| FY2017 | Dec 31, 2017 | -$453.98K | – |
| FY2016 | Dec 31, 2016 | -$1.22M | – |
| FY2015 | Dec 31, 2015 | -$939.33K | – |
| FY2014 | Dec 31, 2014 | -$1.14M | – |
| FY2013 | Dec 31, 2013 | -$230.44K | – |
| FY2012 | Dec 31, 2012 | -$256.41K | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2022 | Dec 31, 2022 | -$6.39K | – |
| Q3 FY2022 | Sep 30, 2022 | -$58.02K | – |
| Q2 FY2022 | Jun 30, 2022 | -$57.85K | – |
| Q1 FY2022 | Mar 31, 2022 | -$57.64K | – |
| Q4 FY2021 | Dec 31, 2021 | -$109.69K | – |
| Q3 FY2021 | Sep 30, 2021 | -$115.72K | – |
| Q2 FY2021 | Jun 30, 2021 | -$250.57K | – |
| Q1 FY2021 | Mar 31, 2021 | -$354.10K | – |
| Q4 FY2020 | Dec 31, 2020 | -$488.51K | – |
| Q3 FY2020 | Sep 30, 2020 | -$446.71K | – |
| Q2 FY2020 | Jun 30, 2020 | -$901.40K | – |
| Q1 FY2020 | Mar 31, 2020 | -$146.27K | – |
| Q4 FY2019 | Dec 31, 2019 | -$202.67K | – |
| Q3 FY2019 | Sep 30, 2019 | -$143.08K | – |
| Q2 FY2019 | Jun 30, 2019 | -$240.36K | – |
| Q1 FY2019 | Mar 31, 2019 | -$419.95K | – |
| Q4 FY2018 | Dec 31, 2018 | -$332.19K | – |
| Q3 FY2018 | Sep 30, 2018 | -$518.49K | – |
| Q2 FY2018 | Jun 30, 2018 | -$164.91K | – |
| Q1 FY2018 | Mar 31, 2018 | -$138.98K | – |
| Q2 FY2017 | Jun 30, 2017 | -$107.72K | – |
| Q1 FY2017 | Mar 31, 2017 | -$67.94K | – |
See a number that looks wrong?